DaVita Inc. (NYSE:DVA) Shares Sold by Mount Lucas Management LP

Mount Lucas Management LP decreased its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 60.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,611 shares of the company's stock after selling 20,522 shares during the quarter. Mount Lucas Management LP's holdings in DaVita were worth $2,231,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. boosted its position in DaVita by 1.5% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company's stock valued at $776,000 after buying an additional 70 shares in the last quarter. Wedmont Private Capital boosted its holdings in shares of DaVita by 4.4% during the 3rd quarter. Wedmont Private Capital now owns 1,776 shares of the company's stock worth $280,000 after buying an additional 75 shares in the last quarter. Blue Trust Inc. increased its stake in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after purchasing an additional 78 shares in the last quarter. First Trust Direct Indexing L.P. increased its position in DaVita by 2.9% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company's stock valued at $500,000 after buying an additional 86 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in DaVita by 0.3% during the third quarter. Nisa Investment Advisors LLC now owns 36,820 shares of the company's stock worth $6,036,000 after buying an additional 126 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Up 3.9 %

Shares of DVA traded up $5.97 during mid-day trading on Friday, hitting $160.33. 1,162,981 shares of the company traded hands, compared to its average volume of 923,358. DaVita Inc. has a 1-year low of $92.68 and a 1-year high of $168.50. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The company has a market capitalization of $13.15 billion, a PE ratio of 17.30, a price-to-earnings-growth ratio of 0.90 and a beta of 0.89. The business has a 50 day moving average of $157.78 and a 200 day moving average of $147.56.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the company posted $2.85 EPS. DaVita's quarterly revenue was up 4.6% compared to the same quarter last year. Equities research analysts anticipate that DaVita Inc. will post 9.71 EPS for the current year.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 64,029 shares of the business's stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the completion of the sale, the chief financial officer now directly owns 111,481 shares in the company, valued at approximately $17,286,243.86. The trade was a 36.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the completion of the sale, the chief executive officer now directly owns 905,659 shares in the company, valued at $141,219,407.87. This represents a 3.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 156,086 shares of company stock worth $24,807,161. 2.00% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. TD Cowen upped their target price on shares of DaVita from $139.00 to $150.00 and gave the stock a "hold" rating in a research note on Wednesday, July 24th. Barclays upped their target price on DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. UBS Group raised their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a "buy" rating in a research note on Thursday, August 8th. Bank of America upped their price objective on shares of DaVita from $139.00 to $145.00 and gave the company an "underperform" rating in a report on Wednesday, August 7th. Finally, Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research note on Monday, October 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $161.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.